Schisandrin B Protects against Acute Ethanol-Induced Cardiac Injury by Downregulating Autophagy via the NOX4/ROS Pathway

Pharmacology. 2021;106(3-4):177-188. doi: 10.1159/000510863. Epub 2021 Jan 22.

Abstract

Introduction: Although oxidative stress has been demonstrated to mediate acute ethanol-induced changes in autophagy in the heart, the precise mechanism behind redox regulation in acute ethanol heart disease remains largely unknown.

Methods: Wild-type C57BL/6 mice were intraperitoneally injected with ethanol (3 g/kg/day) for 3 consecutive days. The effects of ethanol on cultured primary cardiomyocytes and H9c2 myoblasts were also studied in vitro. Levels of autophagic flux, cardiac apoptosis and function, reactive oxygen species (ROS) accumulation, NOX4, and NOX2 were examined. The NOX4 gene was knocked down with NOX4 siRNA.

Results: In this study, we demonstrated that schisandrin B inhibited acute ethanol-induced autophagy and sequent apoptosis. In addition, schisandrin B treatment improved cardiac function in ethanol-treated mice. Furthermore, NOX4 protein expression was increased during acute ethanol exposure, and the upregulation of NOX4 was significantly inhibited by schisandrin B treatment. The knockdown of NOX4 prevented ROS accumulation, cell autophagy, and apoptosis.

Conclusion: These results highlight that NOX4 is a critical mediator of ROS and elaborate the role of the NOX4/ROS axis in the effect of schisandrin B on autophagy and autophagy-mediated apoptosis in acute ethanol exposure, which suggests a therapeutic strategy for acute alcoholic cardiomyopathy.

Keywords: Autophagy; Cardiac injury; Ethanol; NOX4/ROS; Schisandrin B.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Autophagy / drug effects*
  • Autophagy / genetics
  • Cardiomyopathy, Alcoholic / prevention & control*
  • Cyclooctanes / pharmacology
  • Cyclooctanes / therapeutic use
  • Down-Regulation
  • Ethanol / toxicity
  • Gene Knockdown Techniques
  • Heart Injuries / chemically induced
  • Heart Injuries / metabolism
  • Heart Injuries / prevention & control*
  • Lignans / pharmacology*
  • Lignans / therapeutic use
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / pathology
  • NADPH Oxidase 4 / antagonists & inhibitors
  • NADPH Oxidase 4 / genetics
  • NADPH Oxidase 4 / metabolism*
  • Polycyclic Compounds / pharmacology*
  • Polycyclic Compounds / therapeutic use
  • Primary Cell Culture
  • Protective Agents / pharmacology*
  • Protective Agents / therapeutic use
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Signal Transduction / drug effects

Substances

  • Cyclooctanes
  • Lignans
  • Polycyclic Compounds
  • Protective Agents
  • Reactive Oxygen Species
  • schizandrin B
  • Ethanol
  • NADPH Oxidase 4
  • Nox4 protein, mouse